Analyst Price Target is $1.63
▲ +∞ Upside Potential
This price target is based on 1 analysts offering 12 month price targets for IM Cannabis in the last 3 months. The average price target is $1.63, with a high forecast of $1.63 and a low forecast of $1.63. The average price target represents a ∞ upside from the last price of $0.00.
Current Consensus is
The current consensus among 1 polled investment analysts is to buy stock in IM Cannabis.
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.